612 related articles for article (PubMed ID: 16890539)
1. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
Zhao C; Irie N; Takada Y; Shimoda K; Miyamoto T; Nishiwaki T; Suda T; Matsuo K
Cell Metab; 2006 Aug; 4(2):111-21. PubMed ID: 16890539
[TBL] [Abstract][Full Text] [Related]
2. Boning up on ephrin signaling.
Mundy GR; Elefteriou F
Cell; 2006 Aug; 126(3):441-3. PubMed ID: 16901775
[TBL] [Abstract][Full Text] [Related]
3. [Effects of bidirectional EphB4-EphrinB2 signaling on bone remodeling].
Fan WB; Zhao JN; Bao NR
Zhongguo Gu Shang; 2013 Aug; 26(8):705-8. PubMed ID: 24266083
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
[TBL] [Abstract][Full Text] [Related]
5. Preliminary identification of potential PDZ-domain proteins downstream of ephrin B2 during osteoclast differentiation of RAW264.7 cells.
Mao Y; Huang X; Zhao J; Gu Z
Int J Mol Med; 2011 May; 27(5):669-77. PubMed ID: 21373749
[TBL] [Abstract][Full Text] [Related]
6. Communication between ephrinB2 and EphB4 within the osteoblast lineage.
Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA
Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis.
Irie N; Takada Y; Watanabe Y; Matsuzaki Y; Naruse C; Asano M; Iwakura Y; Suda T; Matsuo K
J Biol Chem; 2009 May; 284(21):14637-44. PubMed ID: 19299512
[TBL] [Abstract][Full Text] [Related]
8. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.
Allan EH; Häusler KD; Wei T; Gooi JH; Quinn JM; Crimeen-Irwin B; Pompolo S; Sims NA; Gillespie MT; Onyia JE; Martin TJ
J Bone Miner Res; 2008 Aug; 23(8):1170-81. PubMed ID: 18627264
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast-osteoblast communication.
Matsuo K; Irie N
Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
[TBL] [Abstract][Full Text] [Related]
10. The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors In Vivo.
Ge YW; Feng K; Liu XL; Chen HF; Sun ZY; Wang CF; Liu ZQ; Wang HW; Zhang JW; Yu DG; Mao YQ
Oxid Med Cell Longev; 2020; 2020():1404915. PubMed ID: 32587656
[TBL] [Abstract][Full Text] [Related]
11. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
[TBL] [Abstract][Full Text] [Related]
13. Claudin 11 regulates bone homeostasis via bidirectional EphB4-EphrinB2 signaling.
Baek JM; Cheon YH; Kwak SC; Jun HY; Yoon KH; Lee MS; Kim JY
Exp Mol Med; 2018 Apr; 50(4):1-18. PubMed ID: 29700355
[TBL] [Abstract][Full Text] [Related]
14. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of ephrinB2 in periodontal ligament stem cells (PDLSCs) modulates osteogenic differentiation via signaling crosstalk between ephrinB2 and EphB4 in PDLSCs and between PDLSCs and pre-osteoblasts within co-culture.
Zhu SY; Wang PL; Liao CS; Yang YQ; Yuan CY; Wang S; Dissanayaka WL; Heng BC; Zhang CF
J Periodontal Res; 2017 Jun; 52(3):562-573. PubMed ID: 27763659
[TBL] [Abstract][Full Text] [Related]
16. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.
Asagiri M; Sato K; Usami T; Ochi S; Nishina H; Yoshida H; Morita I; Wagner EF; Mak TW; Serfling E; Takayanagi H
J Exp Med; 2005 Nov; 202(9):1261-9. PubMed ID: 16275763
[TBL] [Abstract][Full Text] [Related]
17. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.
Sato K; Suematsu A; Nakashima T; Takemoto-Kimura S; Aoki K; Morishita Y; Asahara H; Ohya K; Yamaguchi A; Takai T; Kodama T; Chatila TA; Bito H; Takayanagi H
Nat Med; 2006 Dec; 12(12):1410-6. PubMed ID: 17128269
[TBL] [Abstract][Full Text] [Related]
18. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
Tsuji-Naito K
Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling.
Li C; Shi C; Kim J; Chen Y; Ni S; Jiang L; Zheng C; Li D; Hou J; Taichman RS; Sun H
J Dent Res; 2015 Mar; 94(3):455-63. PubMed ID: 25586589
[TBL] [Abstract][Full Text] [Related]
20. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
Zamora DO; Babra B; Pan Y; Planck SR; Rosenbaum JT
Cell Immunol; 2006 Aug; 242(2):99-109. PubMed ID: 17123494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]